| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/28/2009 | US20090136912 Carrier for cell culture |
| 05/28/2009 | US20090136624 Lactic acid bacteria producing nisin at high concentration and method for selecting the same |
| 05/28/2009 | US20090136557 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 05/28/2009 | US20090136536 Recombinant Subunit Vaccine |
| 05/28/2009 | US20090136532 Vaccine for Avian Influenza and Methods of Use |
| 05/28/2009 | US20090136530 Influenza Hemagglutinin and Neuraminidase Variants |
| 05/28/2009 | US20090136528 Novel immunogenic epitope for immunotherapy |
| 05/28/2009 | US20090136525 Immunoglobulins Comprising Predominantly a Glcnacman3Glcnac2 Glycoform |
| 05/28/2009 | US20090136510 Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof |
| 05/28/2009 | US20090136508 Method of diagnosing colon and gastric cancers |
| 05/28/2009 | US20090136507 HBM variants that modulate bone mass and lipid levels |
| 05/28/2009 | US20090136506 Conserved Membrane Activator of Calcineurin (CMAC), a Novel Therapeutic Protein and Target |
| 05/28/2009 | US20090136501 Compositions and methods for treating coagulation related disorders |
| 05/28/2009 | US20090136498 Method for Manufacturing Recombinant Polyclonal Proteins |
| 05/28/2009 | US20090136495 useful therapeutically for increasing serum iron levels, reticulocyte count, red blood cell count, hemoglobin, and/or hematocrit in a human; anemia |
| 05/28/2009 | US20090136491 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/28/2009 | US20090136484 Novel antibody molecules and nucleic acids |
| 05/28/2009 | US20090136476 Arabinofuranosidases |
| 05/28/2009 | US20090136467 Apolipoprotein analogues |
| 05/27/2009 | EP2062977A1 Fucosyltransferase-gen |
| 05/27/2009 | EP2062976A2 Site specific incorporation of keto amino acids into proteins |
| 05/27/2009 | EP2062974A1 Method of producing fused protein |
| 05/27/2009 | EP2062967A1 Genetically engineered aspergillus |
| 05/27/2009 | EP2061897A2 High-cell density fed-batch fermentation process for producing recombinant protein |
| 05/27/2009 | EP2061887A1 Vlp based vaccine delivery system |
| 05/27/2009 | EP2061878A2 Hybrid suppressor trna for vertebrate cells |
| 05/27/2009 | EP2061805A1 Recombinant hcv e2 glycoprotein |
| 05/27/2009 | EP2061800A2 Compositions comprising hmw-maa and fragments thereof, and methods of use thereof |
| 05/27/2009 | EP2061511A2 Smallpox monoclonal antibody |
| 05/27/2009 | EP2061339A1 A method for preparing protein concentrate from rice bran |
| 05/27/2009 | EP1641910A4 Glucanases, nucleic acids encoding them and methods for making and using them |
| 05/27/2009 | EP1366075B1 New interferon beta-like molecules |
| 05/27/2009 | EP1343880B1 Expression of xenogenous (human) immunoglobulins in cloned, transgenic bovine |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | EP1200476B1 Antitumor antibodies, proteins, and uses thereof |
| 05/27/2009 | EP0959899B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 05/27/2009 | CN101440390A Method for preparing vegetable seed active peptide by mixed bacteria solid-state fermentation |
| 05/27/2009 | CN100491527C Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3 |
| 05/27/2009 | CN100491397C Method and compositions for generating human monoclonal antibodies |
| 05/27/2009 | CN100491394C Anti-angiogenic polypeptides |
| 05/27/2009 | CN100490895C CD40-binding APC-activating molecules |
| 05/26/2009 | US7538209 Lactobacillus acidophillus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 05/26/2009 | US7538208 Expression vector comprising nucleotide sequences coding portion of ADP-ribosylating toxin for use treatment and prevention of gramnegative bacterial infection |
| 05/26/2009 | US7538207 Polyepitope carrier protein |
| 05/26/2009 | US7538200 Thermal tolerant avicelase from Acidothermus cellulolyticus |
| 05/26/2009 | US7538195 Antibodies that bind to human insulin-like growth factor-I receptor; particularly, antibodies that inhibit the cellular functions of the IGF-I receptor; cancer treatment |
| 05/26/2009 | US7538086 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders |
| 05/26/2009 | US7538084 Cyclosporins |
| 05/26/2009 | US7537931 a cancer which expresses epidermal growth factor receptor; blocking ligand activation of a receptor; binding of monoclonal antibody 2C4 to ErbB2; chemotherapeutic agents are 5-fluorouracil leucovorin, levamisole |
| 05/26/2009 | US7537930 Mammalian cell lines for increasing longevity and protein yield from a cell culture |
| 05/26/2009 | US7537919 Cytochrome P450RAI-2 and related proteins |
| 05/26/2009 | US7537915 Nucleic acids encoding chromophores/fluorophores and methods for using the same |
| 05/26/2009 | US7537914 Nucleic acid and allergenic polypeptides encoded thereby in cashew nuts (Anacardium occidentale) |
| 05/26/2009 | US7537771 Produces an immune response which is protective against Bacillus anthracis |
| 05/26/2009 | US7537763 Tumor necrosis factor specific immunoglobulin for use in treatment and prevention of tumor disorder; tissue targeted therapy |
| 05/26/2009 | US7537755 Interferon-alpha polypeptides and conjugates |
| 05/26/2009 | CA2497857C Novel p-selectin ligand protein |
| 05/26/2009 | CA2450691C Genes and proteins involved in the biosynthesis of lipopeptides |
| 05/26/2009 | CA2295936C Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 05/26/2009 | CA2230492C Human growth hormone variants |
| 05/26/2009 | CA2091102C Microsomal triglyceride transfer protein |
| 05/22/2009 | WO2009064913A1 Chimer containing a targeting portion linked to a scission-activated duocarmycin-type prodrug |
| 05/22/2009 | WO2009064815A1 Production of cytotoxic antibody-toxin fusion in eukaryotic algae |
| 05/22/2009 | WO2009063965A1 Monoclonal antibody capable of binding to anexelekto, and use thereof |
| 05/22/2009 | WO2009063647A1 Antibody production method |
| 05/22/2009 | WO2009062348A1 Methods for inhibiting influenza virus infection and their drugs |
| 05/22/2009 | WO2009035412A8 Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
| 05/22/2009 | CA2706549A1 Monoclonal antibody capable of binding to anexelekto, and use thereof |
| 05/21/2009 | US20090133164 EG1117 polynucleotides and uses thereof |
| 05/21/2009 | US20090133160 Polyoleosins |
| 05/21/2009 | US20090133159 Soybean ef1a2 promoter and its use in constitutive expression of transgenic genes in plants |
| 05/21/2009 | US20090133134 Method and composition for genetically modifying non-human cells and animals |
| 05/21/2009 | US20090131645 used to control the interaction of particular cell types with their external environment; for chronic pain; reduced side effects, long-lasting actions that do not require frequent injections or long-term catheterization; does not lead to tolerance and associated dependence |
| 05/21/2009 | US20090131637 Vanilloid receptor |
| 05/21/2009 | US20090131634 Method for Preparing Cell Fraction Containing Hemangioblasts |
| 05/21/2009 | US20090131331 Novel Nutraceutical Compositions |
| 05/21/2009 | US20090131319 Protein of given amino acid sequence; heterologous polypeptide comprises Fc portion of antibody molecule; identifying agonists and antagonists; diagnosis and treatment of disease resulting from aberrant cell proliferation |
| 05/21/2009 | US20090131318 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 05/21/2009 | US20090131312 Non-natural chemokine receptor ligands and methods of use thereof |
| 05/21/2009 | US20090130737 Novel fungal proteins and nucleic acids encoding same |
| 05/21/2009 | US20090130716 Rationally designed antibodies |
| 05/21/2009 | US20090130715 Antibodies to CD40 |
| 05/21/2009 | US20090130714 Process for purifying recombinanat tissue plasminogen activator (TPA) |
| 05/21/2009 | US20090130713 Trichoderma promoter |
| 05/21/2009 | US20090130712 Compositions and Methods of Producing Hybrid Antigen Binding Molecules and Uses Thereof |
| 05/21/2009 | US20090130711 Recombinant vector capable of increasing secretion of koji mold protease |
| 05/21/2009 | US20090130710 Enhancing vegetative protein production in transgenic plants using seed specific promoters |
| 05/21/2009 | US20090130709 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 05/21/2009 | US20090130708 Dipeptide crystals and process for production thereof |
| 05/21/2009 | US20090130692 Use of microproteins as tryptase |
| 05/21/2009 | US20090130676 Interaction trap systems for detecting protein interactions |
| 05/21/2009 | US20090130675 Genes Involved in the Biosynthesis of Thiocoraline and Heterologous Production of Same |
| 05/21/2009 | US20090130674 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 05/21/2009 | US20090130255 Catalase Gene and Use Thereof |
| 05/21/2009 | US20090130136 Chondroitin Sulphate a Binding Domains |
| 05/21/2009 | US20090130130 Mutant allergen(s) |
| 05/21/2009 | US20090130126 Dna expression vectors |
| 05/21/2009 | US20090130123 Antibodies to west nile virus polypeptides |
| 05/21/2009 | US20090130120 monoclonal antibodies and fragments that bind to conserved epitopes of the G protein of respiratory syncytial virus(RSV) and which are minimally immunogenic when administered to humans, useful in treating RSV infections |
| 05/21/2009 | US20090130113 Compositions and methods for use for antibodies against sclerostin |